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Abstract
MicroRNAs interact with multiple mRNAs resulting in their degradation and/or translational repression. This report used the
delayed implantation model to determine the role of miRNAs in blastocysts. Dormant blastocysts in delayed implanting
mice were activated by estradiol. Differential expression of 45 out of 238 miRNAs examined was found between the
dormant and the activated blastocysts. Five of the nine members of the microRNA lethal-7 (let-7) family were down-
regulated after activation. Human blastocysts also had a low expression of let-7 family. Forced-expression of a family
member, let-7a in mouse blastocysts decreased the number of implantation sites (let-7a: 1.160.4; control: 3.860.4) in vivo,
and reduced the percentages of blastocyst that attached (let-7a: 42.068.3%; control: 79.065.1%) and spreaded (let-7a:
33.562.9%; control: 67.363.8%) on fibronectin in vitro. Integrin-b3, a known implantation-related molecule, was
demonstrated to be a target of let-7a by 39-untranslated region reporter assay in cervical cancer cells HeLa, and Western
blotting in mouse blastocysts. The inhibitory effect of forced-expression of let-7a on blastocyst attachment and outgrowth
was partially nullified in vitro and in vivo by forced-expression of integrin-b3. This study provides the first direct evidence
that let-7a is involved in regulating the implantation process partly via modulation of the expression of integrin-b3. (200
words).
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Introduction
Mature microRNAs (miRNAs) are endogenous non-coding
RNAs with a size of about ,21 nt. It has been estimated that
miRNAs constitute about 0.5–1% of the genes of different species
[1] and that humans may have over 1000 miRNAs (miRBase,
April 2011, http://www.mirbase.org/index.shtml). MiRNAs have
been found in Caenorhabditis elegans, Drosophila, mice and humans,
suggesting a conservative role for these RNAs [2]. They bind to
target mRNAs inducing their cleavage and/or inhibiting their
translation [1,3,4]. MiRNAs are involved in diverse biological
processes, including morphogenesis and maintenance of tissue, cell
growth, differentiation, apoptosis and metabolism [5,6].
Several observations suggest that miRNAs are involved in early
preimplantation embryo development. First, the expression profile
of miRNA in preimplantation embryos undergoes dynamic
changes during development [7–9]. Second, mouse oocytes
without a miRNA processing enzyme, dicer possess much reduced
amount of miRNAs, disorganized spindle, and their resulting
zygotes cannot cleave [7–9]. Dicer-deficient embryos carrying
maternal dicer can only survive to E7.5 [10]. Third, knockdown of
Argonaute 2, a catalytic component of the miRNA functioning
machinery, RNA-induced silencing complex (RISC), resulted in
cleavage arrest of early embryos at the two-cell stage [11]. Fourth,
our recent data further confirmed that miR-34c and miR-135a are
involved in first cleavage in mouse zygotes [12,13].
Implantation of blastocysts onto the receptive endometrium is
crucial to mammalian reproduction. The process is under
endocrine, paracrine, autocrine, and juxtacrine regulation [14].
Recent studies suggest that endometrial miRNAs are involved in
the process. MiR-101a and miR-199a* regulate uterine expression
of cyclooxygenase-2 around the implantation site [15]. The
presence of blastocyst induces the expression of miR-320 and
let-7a in the rat uterus during the implantation window [16,17].
However, there is no study on the role of miRNAs in blastocysts
during implantation.
Delayed implantation in mice is an important model for
investigation of the implantation process. In this model, dormant
blastocysts in the progesterone-primed uterus can be activated
within 1 hour after estradiol treatment [18]. The activation is
associated with a change in the mRNA expression of blastocysts
[19]. We hypothesized that miRNAs were involved in regulating
blastocyst implantation. To address this question, we compared
the miRNA expression between dormant and activated blastocysts
at 3-hour after estradiol treatment in the delayed implantation
model. We further demonstrated that one of the differentially
expressed miRNAs, let-7a, affects implantation via its action on
the expression of integrin in blastocysts.
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Animals and Embryo Collection
The protocol of this study was approved by the Committee on
Use of Live Animals in Teaching and Research, the University of
Hong Kong (Approval no. 2070-10). ICR female mice aged 6–8
weeks were mated with fertile males. The morning of finding
a vaginal plug was designated as Day 1 of pregnancy. To induce
delayed implantation, pregnant mice were ovariectomized in the
morning (0800–0900 h) of Day 4 and maintained by daily
subcutaneous injection of progesterone (2 mg/mouse) from Days
5–7 [18]. Dormant blastocysts were activated by injection of
estradiol (25 ng/mouse) into progesterone-primed delayed im-
planting pregnant mice on Day 7 [19]. Blastocysts were recovered
by flushing the uteri with M2 medium at 3–4 hours post-estradiol
injection, and were stored at 280uC until use.
Fresh human oocytes and cryopreserved embryos were donated
from couples attending the assisted reproduction program at
Queen Mary Hospital. The couples gave written consent to the
donation of oocytes when no spermatozoa could be isolated from
the husband’s testicular biopsies on the day of oocyte retrieval and
to the donation of embryos when the couples had a completed
family following assisted reproduction treatment. The Institutional
Review Board of the University of Hong Kong/Hospital Authority
Hong Kong West Cluster approved the protocol (Approval no.
UW07-067).
MiRNA Profiling
Three batches of dormant and activated blastocysts in groups of
5 were collected. The embryos were lysed in 0.5 mlo f2 M
guanidine isothiocyanate at room temperature for 5 minutes
before the samples were diluted to 5 ml with distilled water for the
238-plex miRNA assay (Applied Biosystems, Foster City, CA).
Human oocytes and embryos at different stages of development (2-
cell, 4-cell, 8-cell embryos, morulae and blastocysts) were collected
and lysed using the same method. Their miRNA expression
profiles were determined by the 330-plex miRNA assay (Applied
Biosystems). Both assays consisted of three steps: reverse
transcription, stem-loop preamplification and quantitative poly-
merase chain reaction (qPCR) [20]. Reverse transcription was
performed in a 10 ml solution containing 1 mlo f1 0 6 cDNA
Archiving kit buffer, 100 U of MMLV reverse transcriptase,
5 mM of dNTP, 2.6 U of RNase inhibitor, 50 nM of reverse
transcription primers for the studied miRNAs, 3.425 mM of
MgCl2 and 4.5 ml of total RNA. The reaction conditions were:
16uC for 30 minutes, followed by 60 cycles of 20uC for 30 seconds,
42uC for 30 seconds and 50uC for 1 second. The enzyme was
eventually inactivated at 85uC for 5 minutes.
Stem-loop preamplification involved amplification of the
cDNA in 50 ml of pre-PCR solution containing 25 mlo f2 6
TaqManH Universal Master Mix with no AmpEraseH UNG,
10 ml of cDNA product, 50 nM of 238-plex forward primer for
each miRNA, 5 nM of universal reverse primer, 12.5 U of
AmpliTaq Gold, 2 mM of dNTP, 2 mM of MgCl2 and 3 mlo f
ddH2O. The PCR condition was 95uC for 10 minutes, 55uC for
2 minutes, followed by 18 cycles of 95uC for 1 second and
65uC for 1 minute.
Quantitative PCR was performed with 50 ml of the pre-
amplified sample, which was diluted to 300 ml with water. The
qPCR mixture contained 5 mlo f2 6Universal Master Mix with
no AmpEraseHUNG, 0.5 mM of forward primer and 1 mMo f
TaqMan probe mixture, 1 mM of universal reverse primer, 1 mlo f
diluted pre-amplified RT-PCR sample, and 0.9 ml of double
distilled water. The qPCR condition was 95uC for 10 minutes,
followed by 40 cycles at 95uC for 15 seconds, and 60uC for 1
minute. The reactions were performed in an ABI 7500 Real-time
PCR System.
Preparation of Mouse Integrin Beta 3 cRNA
The expression construct of full-length integrin beta 3 (itgb3)
was kindly provided by Prof. B.A. Imhof (Centre Medical
Unversitaire, Switzerland) [21]. The full-length cDNA of mouse
itgb3 was cloned into the BamH1/XhoI site of pcDNA3 which
contains a T7 promoter. Plasmid containing itgb3 sequence was
linearized. cRNA was synthesized by the mMessage mMachine
T7 kit (Ambion, Austin, TX) and purified with the Rneasy Mini
Kit (Qiagen) according to the manufacture’s protocol.
Electroporation and Uterine Embryo Transfer
The oviducts of Day 3 pregnant mice were flushed with Hank’s
solution to obtain early 8-cell embryos, which were washed
thoroughly and transferred to pre-warmed droplets of KSOM/AA
culture medium (Chemicon, Billerica, MA) overlaid with paraffin
oil. Precursor of let-7a (pre-let-7a), scramble control (Exiqon,
Denmark) or itgb3 RNA, were electroporated into the 8-cell
embryos in a flat electrode chamber (1 mm gap between
electrodes) (BTX Inc., San Diego, CA) in 20 ml of hepes-buffered
saline (150 mM NaCl, 20 mM HEPES) by two sets of 3 electric
pulses of 1 ms at 30 V using a 830 Electro Square Porator (BTX
Inc.). Following electroporation, the embryos were cultured in
fresh KSOM/AA medium. The survival rate of the electroporated
embryos was calculated as the percentage of embryos with no sign
of cell lysis at 2-hour post-electroporation relative to the total
number of electroporated embryos. After 36 hours of culture, 5
blastocysts were transferred into each uterine horn of Day 3
pseudo-pregnant female mice. For assessing the mature let-7a level
in embryos upon pre-let-7a electroporation, quantitative PCR was
performed on embryos at 24-hour post-electroporation as de-
scribed [12,13]. To determine the level of itgb3 protein upon
forced-expression, Western blotting was performed on embryos at
24-hour post-electroporation.
Mouse Embryo Attachment and Outgrowth Assay
Attachment and outgrowth assays were conducted on plastic
culture dishes precoated with fibronectin (FN-120) as described
[22]. The plastic surface was rinsed three times with fresh culture
medium before use. The zona pellucida of blastocysts was
removed by acid tyrode. The denuded blastocysts were cultured
in microdrops on the fibronectin-coated plate for 72 hours. To
determine attachment, the plate was shaken at a rate of one
rotation/second on an orbital shaker for 20 seconds. Blastocysts
that remained at the same location were designated as attached
blastocysts. Outgrowth was identified as the area covered by
trophoblast monolayer around the embryo under an inverted
microscope with phase contrast optics. The outgrowth area was
measured by capturing the image of the outgrowth of 10–15
blastocysts followed by analysis of the images using the Image-Pro
software (Media Cybernetics, Inc., MD). Each experiment was
repeated three times.
Luciferase Reporter Assay
A 996 bp oligonucleotide corresponding to a fragment of the 39-
untranslated region (UTR) of mouse itgb3 was synthesized
according to the sequence of potential binding regions predicted
by two online miRNA target prediction programs, MiRanda
(http://www.microrna.org/microrna/) and TargetScan (http://
www.targetscan.org/). Specific primers (Forward: 59-CAGGTT-
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CAGGCGGCCGCGCACGTTGTTCAACAGACTC-39) for
PCR were manufactured by Invitrogen (Carlsbad, CA). The
PmeI and NotI restriction enzyme digested and purified amplicons
were cloned downstream of the Renilla luciferase gene within the
PmeI-NotI treated psiCHECK-2 vector (Promega, Madison, WI)
to generate the wild type reporter construct. The positive clone
was two-nucleotide-point mutated at the let-7a complementary site
using the QuikChange II Site Directed Mutagenesis Kit
(Stratagene, La Jolla, CA) according to the manufacturer’s
protocol. The mutant sequence was 59…TGTGTATC-
gAgCTCTTCGGTGTCTT…39. Relative luciferase activities
were determined by normalizing the renilla luciferase activity
against the firefly luciferase activity.
Western Blot Analysis
Western blotting was performed as previously described [23]. In
brief, 40 blastocysts were pooled and rinsed twice in PBS,
resuspended in 10 ml of Laemmli Buffer [24] and boiled for 10
minutes. The samples were run in 10% SDS-PAGE gels. To
increase the sensitivity of the assay, the samples in each lane was
concentrated by reducing the width of the sample wells to 2 mm
with a home-made sample comb. Protein bands in the gel were
transferred onto nitrocellulose membranes, which were incubated
with the primary antibodies in Tris-buffered saline containing 5%
nonfat milk and 0.5% Tween 20 (TBST) overnight at 4uC,
followed by incubation with appropriate horseradish peroxidase
conjugated secondary antibody (1:1000) in TBST for 1 hour. The
bands were detected using an enhanced chemiluminescence kit
(Santa Cruz Biotechnology, Santa Cruz, CA).
Data Analysis
Statistical analysis of the 238-plex miRNA data was performed
with the GeneSpring
TM software version 7.3 (Sigenetics Inc., San
Carlos, CA). One-way ANOVA non-parametric t-test for paired
comparison was applied. A difference with p-value of less than
0.05 was considered as significant. Values for each miRNA were
median-centered before clustering. For analysis of the possible
function of the miRNAs differentially expressed between the
dormant and activated blastocysts, their potential target genes
were searched using TargetScan. The predicted target gene list
from the up- and the down-regulated miRNAs were grouped
Figure 1. MicroRNA profiling of dormant and activated mouse blastocysts. (a) Supervised hierarchical clustering of the expression of 238
miRNAs in mouse dormant and activated blastocysts. Heat map shows normalized, log-transformed relative intensities of the studied miRNA. Red,
green and black color represent low, high and mean expression levels of miRNAs, respectively. Genes with similar expression patterns are grouped
together. (b) Validation of expression of miR-34a, -20a, -140, and -16 by qPCR without pre-amplification. The expression patterns of these miRNAs in
dormant and activated blastocyst were similar to those determined by miRNA profiling. All values are calculated against the CT values of dormant
blastocysts and are presented as relative fold-change. (c) Relative expression of let-7a and let-7e in dormant, activated and normal Day 4 blastocysts
as determined by qPCR without pre-amplification (
a–b, c–d denote P,0.05 between corresponding groups). (d) The expression of let-7 in human
embryos.
doi:10.1371/journal.pone.0037039.g001
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using Mus musculus gene list as background.
Results
Activation of Dormant Blastocysts is Associated with
Changes in microRNAs Expression
The 238-multiplex kit specific for mouse miRNAs was used to
determine the miRNAs profiles in dormant and activated
blastocysts. To reduce variation, groups of 5 blastocysts were used
for each datum, and the experiment was repeated thrice. The
relative levels of miRNA expression in the dormant and the
activated blastosysts were compared by the average difference
values. Supervised hierarchical clustering analysis using the
Genespring software is shown in Fig. 1a. One way ANOVA
analysis revealed that 45 miRNAs (18.9%) were differentially
expressed between the dormant and the activated blastocysts
(P,0.05). Of these miRNAs, 38 were up-regulated and 7 were
down-regulated in the dormant blastocysts when compared with
the activated blastocysts (Table 1). Several miRNA clusters were
observed among the differentially expressed miRNAs. These
include the miR-17,92 (miR-17-5p, -18, -19b, -20), 15a/16 (miR-
15a, -15b), and 290–295 (miR-290, -294, -295) clusters. Several
members of the let-7 family (let-7a, -7d, -7e, -7f, -7g) were also
found in the list.
To confirm the data obtained from the miRNA profiling
experiment, total RNAs isolated from 5 pools of dormant and
activated blastocysts were subjected to direct qPCR analysis
without pre-PCR amplification for 4 miRNAs. The results
(Fig. 1b) confirmed that the expression patterns of miR-20a,
miR-34a, miR-140 and miR-16 were consistent with those
obtained after pre-PCR amplification. Apart from miR-16,
significant differences in the levels of these miRNAs were found
between the dormant and the activated blastocysts.
The potential target genes of the differentially expressed
miRNAs as predicted by TargetScan were subjected to biological
processes and pathway analysis by PANTHER [26]. The top 10
biological processes and signaling pathways are shown in Tables 2
and 3, respectively. The biological processes predicted from the
target genes of both up- and down-regulated miRNAs (P,10
226)
were identical and included metabolic processes, cellular and
developmental process, cell communication, cell cycle, signal
transduction and intracellular signaling cascade, consistent with
the expected difference in biological activities between the
dormant and the activated blastocysts. In the pathway analysis,
Wingless (Wnt) signaling, transforming growth factor-b (TGFb)
signaling, epidermal growth factor (EGF) receptor signaling, Rat
Sarcoma (Ras), integrin signaling and platelet-derived growth
factor (PDGF) signaling, phosphoinositide 3-kinase (PI3-K) and
angiogenesis pathways were predicted from both the up- and the
down-regulated miRNAs (P,10
27).
The Expression of Let-7a is Low in Blastocyst before
Implantation
Nine members of the let-7 family were analyzed in the profiling
experiment. Five of them (let-7a, -7d, -7e, -7f and -7g) were down-
regulated by more than 2-fold in the activated blastocysts (Table 4).
The expression of two members (let-7c and -7i) were below the
detection limit while that of the rest (let-7d* and -7b) did not
change after activation. To confirm the observation, the levels of
let-7a and -7e in normal, dormant and activated blastocysts were
compared by direct qPCR. The results showed that their
expression levels were significantly higher in the dormant
blastocysts than the other 2 types of blastocysts (Fig. 1c).
To determine whether a low level of let-7 also occurred in
human blastocysts, donated human embryos cryopreserved at the
2–4-cell stage were thawed and cultured to blastocysts. Individual
donated fresh human oocytes and cultured human embryos at 2-
cell, 4-cell, 8-cell, morula and blastocyst stages were subjected to
the 330-multiplex miRNA assay (n=3 for each). Similar to the
report in mouse [9], a continuous decrease of expression levels of
let-7 family members was found during preimplantation de-
velopment of human embryos (Fig. 1d).
Let-7a Inhibits Embryo Implantation in vivo
In view of the high level of let-7 in dormant embryos, we
postulated that up-regulation of let-7 suppress blastocyst implan-
tation. Here, we studied the let-7 function by forced expression of
precursor of let-7 in embryos using electroporation as described for
studying the roles of specific genes in mouse preimplantation
embryo development [27,28]. The optimal conditions for electro-
poration of 8-cell embryos in microslide chamber was found to be
two series of three 1 ms pulses of 30 V. Using Cy3-labeled
scramble RNA as a visual indicator of successful electroporation,
fluorescence was detected in all the electroporated embryos
(Fig. 2a). The survival rate of the electroporated embryos was
more than 95% under such conditions. Eighty-two percent of the
electroporated embryos developed to blastocysts after 30 hours of
culture. The blastulation rates were similar between blastocysts
electroporated with pre-let-7a and those with control RNA.
To investigate the role of let-7a in implantation of blastocysts, 8-
cell embryos were electroporated with pre-let-7a or control
precursor. After 30 hours of culture, the blastocysts derived from
embryos electroporated with pre-let-7a expressed 110 times more
mature let-7a than those with control RNA (Fig. 2b). The two
groups of blastocysts were transferred into opposite uterine horns
(5 embryos per horn) of Day 3 pseudopregnant mice. The
numbers of implantation sites were determined on Day 8 of
pregnancy. We found that forced-expression of let-7a in embryos
resulted in a significant reduction in the number of implantation
sites (1.160.4) when compared with those electroporated with
control precursor (3.860.4) (Fig. 3).
Let-7a Inhibits Embryo Attachment and Outgrowth in
vitro
In order to confirm the action of let-7a on the implantation
process, 8-cell embryos were electroporated with pre-let-7a or
control precursor, and the ability of the resulting blastocysts
attaching onto fibronectin was determined. At 36-hour post-
electroporation, the percentage of attached blastocysts with forced-
expression of let-7a (42.068.3%) was significantly lower than that
of blastocysts with control precursor (79.065.1%) (Fig. 4a). The
percentage of the former group of blastocysts with trophoblast
outgrowth (33.562.9%) was also lower than that of the latter
group (67.363.8%) at 48-hour post-electroporation (Fig. 4b),a t
which most of the blastocysts electroporated with pre-let-7a
exhibited only early signs of spreading. The trophoblast migratory
activity was quantified by the area of trophoblast outgrowth at 72-
hour post-electroporation. The results showed that the outgrowth
area was also significantly decreased with let-7a forced-expression
(pre-let-7a 5488569880 mm
2 vs control 2675364976 mm
2;
Fig. 4c).
Let-7a Directly Targets Mouse Integrin-b3 Subunit
TargetScan and MiRanda predicted integrin-b3 as a potential
target gene of let-7a (Fig. 5a). To characterize the relationship
between let-7a and integrin-b3 expression, wild type or mutated
Let-7a and Embryo Implantation
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into HeLa cells for dual luciferase assay. Cells electroporated with
let-7a precursor significantly suppressed the wild type reporter
activity by 50% (Fig. 5b). This effect was abrogated when the
mutated reporter construct was used. Electroporation of the cells
with the empty reporter vector or co-electroporating them with the
scramble controls did not affect the luciferase activities. The results
demonstrated that let-7a directly interacted with the 39UTR of
mouse integrin-b3.
To confirm that let-7a also regulated integrin-b3 expression in
blastocysts, the expression of integrin-b3 protein in blastocysts at
36-hour post-electroporation of either let-7a precursor or control
RNA was examined. Western blot analysis showed that the let-7a
precursor decreased the expression of integrin-b3 protein in
blastocysts (Fig. 5c).
Forced-expression of Integrin-b3 Partially Rescues the
Inhibitory Effects of Let-7a
To determine whether integrin-b3 mediated the action of let-7a
on embryo implantation, ectopic expression of integrin-b3 was
used to nullify the inhibitory activity of let-7a precursor. The level
of integrin-b3 protein significantly increased in embryos electro-
Table 1. MicroRNAs differentially expressed between dormant and activated blastocysts (p,0.05).
Up-regulated miRNA fold change (activated/dormant) Down-regulatedmiRNA fold change (activated/dormant)
miR-376b 505610 miR-410 0.52
miR-20 16.07 miR-200b 0.46
miR-133a 9.25 miR-101b 0.43
miR-199a 5.20 miR-350 0.44
miR-483 2.78 miR-339 0.40
miR-181a 2.54 miR-141 0.29
miR-324-3p 2.22 miR-15b 0.26
let-7g 0.25
miR-26b 0.25
miR-292-5p 0.22
miR-18 0.20
miR-19b 0.18
miR-155 0.18
miR-196b 0.17
miR-295 0.17
miR-424 0.17
let-7d 0.16
miR-203 0.16
miR-10b 0.14
miR-345 0.14
miR-26a 0.12
miR-328 0.12
miR-341 0.12
miR-297 0.11
miR-15a 0.10
miR-127 0.09
miR-294 0.08
miR-429 0.08
let-7e 0.07
miR-24 0.07
miR-324-5p 0.05
let-7a 0.03
let-7f 0.03
miR-34a 0.03
miR-140 0.02
miR-17-5p 0.01
miR-290 0.01
miR-149 0.0003
doi:10.1371/journal.pone.0037039.t001
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(Fig. 6a,b). Forced-expression of integrin-b3 did not affect the
percentages of embryo that attached (integrin b3 82.567.8% vs
control 81.2611.1%) and spread (integrin b3 69.368.1% vs
control 67.166.5%) on fibronectin. Electroporation of pre-let-7a
alone inhibited the ability of the embryo for attachment and
spreading, while co-electroporation with integrin-b3 RNA par-
tially reduced these suppressive actions of pre-let-7a (Fig. 6c and
d). Forced-expression of integrin-b3 also reduced the inhibitory
action of pre-let-7a on implantation in vivo (Fig. 6e).
Discussion
We hypothesize that miRNAs regulate gene and protein
expression during activation of dormant blastocysts. Comparison
of the miRNA profile in dormant and activated blastosysts showed
differential expression of 45 miRNAs. Vast majority (38/45) of
them were down-regulated after activation. As miRNAs suppress
translation, the presence of more up-regulated miRNAs in the
dormant blastocysts was consistent with the inactive nature of
these embryos. Bioinformatic analysis of the differentially
expressed miRNAs showed that their potential targets are involved
in biological processes known to be implicated in dormancy and its
subsequent activation.
Dormancy is associated with reduction in DNA synthesis, cell
cycling and metabolism [29,30]. In the delayed implantation
mouse model, estrogen-induced activation stimulates mitosis and
increases cell number of the dormant blastocysts in vivo [31],
consistent with the predicted involvement of the potential target
genes of the differentially expressed miRNAs in cell cycle, nucleic
acid metabolism and metabolic processes. Indeed some of the
identified miRNAs have been shown to be related to these
processes in other biological systems. Interestingly, these miRNAs
are all down-regulated in the activated blastocysts relative to the
dormant blastocysts. The expression of miR-34a decreased by
128-fold after activation. Its ectopic expression induces cell cycle
arrest in both primary and tumor-derived cell lines by down-
regulation a panel of genes that promote cell cycle progression
[32]. Two members of the miR-15a/16 cluster, miR-15a and
miR-15b, were also down-regulated in the activated blastocysts.
MiR-34a acts synergistically with these miRNAs to induce G1–G0
arrest in lung cancer [33]. Forced-expression of miR-26a, another
down-regulated miRNA in activated blastocysts, also induces cell
cycle arrest in nasopharyngeal carcinoma [34]. The dormant
blastocysts have reduced rate of glucose oxidation caused by
allosteric inhibition of the rate-controlling enzyme for glycolysis,
phosphofructokinase [35]. Incidentally, the enzyme is a predicted
target (TargetScan) of miR-295, of which the expression is high in
the dormant blastocysts. The observation is also consistent with
the detection of a significant increase in the expression of
phosphofructokinase mRNA in the activated blastocysts [19].
MiR-290-295 cluster consists of eight members. Half of them
(miR-290, -292-5p, -294, -295) were down-regulated in the
delayed implanting blastocysts after estrogen administration. The
cluster is expressed during early embryogenesis and is mouse
embryonic stem cells specific [36]. The cluster inhibits differen-
tiation of mouse embryonic stem cells, and is down-regulated
during differentiation [37,38]. The down-regulation of this cluster
Table 2. Biological processes of the differentially-regulated miRNAs.
Biological Process Genes (REF) Targets of miRNAs
##expected +/2 P value
Up-regulated miRNAs
Primary metabolic process 9122 878 572.72 + 1.72E-53
Nucleobase, nucleoside, nucleotide and nucleic acid metabolic process 4156 499 260.93 + 1.01E-48
Metabolic process 9603 891 602.92 + 2.48E-47
Cellular process 7133 717 447.84 + 4.55E-46
Developmental process 3296 405 206.94 + 2.00E-40
Intracellular signaling cascade 1720 237 107.99 + 2.41E-29
Signal transduction 4858 488 305.00 + 6.88E-28
System development 2222 277 139.51 + 1.16E-27
Cell communication 5033 500 315.99 + 1.33E-27
Cell cycle 2018 255 126.70 + 3.38E-26
Down-regulated miRNAs
Cellular process 7133 1658 1031.06 + 9.47E-106
Primary metabolic process 9122 1967 1318.57 + 3.78E-103
Metabolic process 9603 2000 1388.10 + 5.14E-91
Nucleobase, nucleoside, nucleotide and nucleic acid metabolic process 4156 1034 600.74 + 2.25E-71
Developmental process 3296 857 476.43 + 2.24E-65
Cell communication 5033 1152 727.51 + 2.84E-61
Signal transduction 4858 1101 702.22 + 8.56E-56
Intracellular signaling cascade 1720 509 248.62 + 9.15E-52
System development 2222 606 321.19 + 8.21E-51
Cell cycle 2018 563 291.70 + 7.75E-50
doi:10.1371/journal.pone.0037039.t002
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blastocysts to implant and to differentiate.
Three members of the miR-17-92 clusters (miR-17-5p, -19b, -
18) were down-regulated after activation. In cancer, up-regulation
of miR-17-92 inhibits TGFb signaling [39,40]. Another down-
regulated miRNA, miR-140, also suppresses the TGFb pathway
via repression of Smad3 in the murine multipotential mesenchy-
mal cells [41]. In mouse blastocysts, TGFb binds to the
trophectoderm [42] and regulates trophoblast outgrowth [43]. It
is interesting to note that TGFb immunoreactivities are absent in
the delayed implanting blastocysts but reappeared after activation
Table 3. Pathways of differentially-regulated miRNAs.
Pathways Genes (REF) Targets of miRNAs
## expected +/2 P value
Up-regulated miRNAs
TGF-beta signaling pathway 143 40 8.98 + 1.98E-14
Angiogenesis 193 41 12.12 + 4.67E-11
EGF receptor signaling pathway 138 34 8.66 + 4.88E-11
PDGF signaling pathway 162 37 10.17 + 5.71E-11
PI3 kinase pathway 110 29 6.91 + 2.76E-10
Integrin signalling pathway 185 38 11.62 + 5.87E-10
Interleukin signaling pathway 160 33 10.05 + 7.00E-09
FGF signaling pathway 125 28 7.85 + 1.75E-08
Insulin/IGF pathway-protein kinase B signaling cascade 83 22 5.21 + 3.41E-08
Ras Pathway 80 21 5.02 + 8.10E-08
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase
cascade
36 14 2.26 + 1.23E-07
Wnt signaling pathway 348 50 21.85 + 1.36E-07
Down-regulated miRNAs
Integrin signalling pathway 185 87 26.74 + 1.50E-20
EGF receptor signaling pathway 138 72 19.95 + 1.33E-19
FGF signaling pathway 125 67 18.07 + 6.33E-19
Angiogenesis 193 83 27.90 + 1.86E-17
PDGF signaling pathway 162 68 23.42 + 4.25E-14
Wnt signaling pathway 348 111 50.30 + 6.70E-14
Ras Pathway 80 44 11.56 + 2.50E-13
TGF-beta signaling pathway 143 58 20.67 + 1.12E-11
PI3 kinase pathway 110 47 15.90 + 1.84E-10
p53 pathway 127 51 18.36 + 2.62E-10
doi:10.1371/journal.pone.0037039.t003
Table 4. Expression of let-7 family members (in Ct values) in dormant and activated blastocysts.
MiRNA Dormant (Dor) Activated (Act) fold change Act/Dor
1 2 3 Mean 1 2 3 Mean
mmu-let-7b 18.5 18.0 18.4 18.3 18.6 18.8 18.9 18.8 0.72
mmu-let-7c BD BD BD 2 BD BD BD 22
mmu-let-7d 26.7 26.3 26.5 26.5 BD BD BD 2‘
mmu-let-7e 20.7 20.8 20.9 20.8 24.7 24.5 24.7 24.6 0.07
mmu-let-7i BD BD BD 2 BD BD BD 22
mmu-let-7g 21.6 21.9 21.6 21.7 23.6 23.7 23.9 23.7 0.25
mmu-let-7a 21.2 21.4 21.0 21.2 26.2 26.6 26.5 26.4 0.03
mmu-let-7d* 18.9 18.5 18.2 18.5 19.0 18.9 18.6 18.8 0.80
mmu-let-7f 19.0 19.5 19.2 19.2 24.6 23.9 24.0 24.2 0.03
BD= below detection limit.
doi:10.1371/journal.pone.0037039.t004
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in the TGFb signaling needs to be confirmed.
Apart from TGFb signaling, three other pathways, EGF
receptor signaling, Wnt signaling and PI3 kinase pathway,
predicted by bioinformatic tools were known to be involved
during activation of dormant blastocysts. Activation of dormant
blastocysts is associated with increase of EGF receptor signaling
[46]. The trophectoderm function of activated mouse blastocysts
requires a coordinated activation of the canonical Wnt-b-catenin
signaling and an inhibition of the non-canonical Wnt-RhoA
signaling [47]. A global mRNA profiling study shows that genes
involved in PI3-K signaling including Pik3c2a are increased in
activated blastocysts [19]. The regulation of these pathways in the
delayed implanting blastocyst by the differentially expressed
miRNAs remains to be determined.
MiRNAs inhibit the translation of their targets. Hamatani and
coworkers [19] compared the mRNA expression profiles of
dormant and activated mouse blastocysts. Among the 135
differentially expressed mRNAs identified in the study, only 17
(12.6%) of them are common with the predicted targets of the
differentially expressed miRNAs in the present study. The low
percentage of common mRNAs in the two studies probably
reflects the difference in sampling time. The samples were taken at
3–4 hours post-estrogen administration in the present study
whereas samples at 12–14 hours post-estrogen administration were
used in Hamatani and coworkers’ study.
The let-7 family consists of 11 members, which are conserved in
invertebrates and vertebrates, including humans [48,49]. The
expression of 9 family members was studied. Five of them (let-7a, -
7d, -7e, -7f and -7g) were down-regulated by more than 2-fold
when dormant blastocysts were activated. Let-7 family is widely
demonstrated as a tumor suppressor. Its expression is down-
regulated in many cancers when compared to normal tissue [50–
52]. Let-7 controls cellular proliferation by negatively regulating
RAS and cell cycle-related genes such as cyclin D2, CDK6 and
CDC25A [53]. Down-regulation of let-7 in the activated
blastocysts would enable up-regulation of let-7-response genes,
many of which are oncogenes or cell cycle checkpoint genes,
leading to cell cycle progression, DNA synthesis and cell division.
Increases in cell number and uridine incorporation in dormant
blastocysts are characteristics of activation in utero by estrogen
[19].
The expression of let-7 is dynamically regulated during
oogenesis and early embryonic development [7]. There is
a continuous decrease in its expression from the oocyte to the 8-
cell embryo stage [9]. The present study showed that the
expression level of let-7 family in human blastocysts is also low,
consistent with a similar role of the miRNA in preimplantation
embryo development. The high level of let-7 during dormancy
relative to the normal blastocyst and the down-regulation of let-7
in the activated blastocysts suggest that a low level of let-7 is
beneficial for implantation. Here, we provide the first in vitro and
in vivo evidence that let-7a affects embryo implantation, at least
partly through regulation of expression of integrin-b3. The
evidence include (a) Let-7a bound to the 39UTR region of the
integrin-b3; (b) forced-expression of let-7a reduced the expression
of integrin-b3; and (c) forced-expression of integrin-b3 partially
rescued the suppressive effect of let-7 on blastocyst implantation,
attachment and outgrowth.
Integrins are a family of heterodimeric (a/b) transmembrane
molecules primarily responsible for interaction between the mouse
trophoblasts and the extracellular matrix molecules of the
endometrium [54]. Apart from cell adhesion, integrin binding
transduces intracellular signaling involved in cell migration,
differentiation and survival [55]. Blastocyst adhesion to fibronectin
requires integrin-mediated activation of phosphoinositide-specific
phospholipase C leading to initiation of phosphoinositide signaling
and intracellular calcium mobilization [56].
Figure 2. Electroporation of RNA at the 8-cell embryo stage. (a)
Electroporation of Cy3-labeled scramble RNA. Fluorescence was
detected in all the electroporated embryos. (b) Relative level of mature
let-7a in embryos after electroporation of pre-let-7a at the 8-cell
embryo stage. Each experiment contained 5 embryos and the
experiment was repeated at least 3 times. (*P,0.05, One-way ANOVA).
doi:10.1371/journal.pone.0037039.g002
Figure 3. Precursor of let-7 inhibits embryo implantation
in vivo. Eight-cell embryos were electroporated with precursor of let-
7a or control RNA, and transferred into opposite uterine horns of mice
on Day 3 of pseudopregnancy (5 embryos for each horn). Let-7a
reduced the number of embryos implanted in the uterus. Statistical
significant difference (P,0.05, Chi square) in the number of implanta-
tion sites was found on Day-8 of pregnancy (n=18).
doi:10.1371/journal.pone.0037039.g003
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dormant blastocysts showing reduced a4b1 expression relative to
that of the activated blastocysts [57]. Here we provide evidence
that integrin-b3 mediates the action of let-7a on implantation of
activated blastocysts. The low level of let-7a in the normal
blastocysts and the activated blastocysts would favor the expression
of integrin-b3 subunit. It is interesting to note that integrin av
subunit is one of the target genes of the miR-295 cluster [58],
which is also down-regulated in the activated blastocysts. These
observations suggest that integrin avb3 would be up-regulated in
the activated blastocysts, consistent with the report that avb3 is the
only integrin among a repertoire of integrins expressed in mouse
embryos detected on the apical surface of the trophectoderm of
late blastocysts and the proposal that integrin avb3 mediates
primary trophoblast adhesion and migration [59].
Differentiation of the trophectoderm cells into trophoblast cells is
associated with translocation of the integrins a5b1 [54] and aIIbb3
[60,61], and increased binding ability to fibronectin [54]. The
fibronectin-binding activity of blastocyst depends on integrins a5b1
andavb3[62].Theimportanceofintegrinsinimplantationisshown
by significant reduction of implantation after injection of echistatin,
which inactivates avb3, a5b1 and aIIbb3, into the uterine horns
[63,64].Itislikelythattheseintegrinshavecompensatoryfunctionin
implantationasmicelackingintegrin-b3arefertileandtheirembryos
are compatiblewith implantation [65].
Apart from the possible compensatory function of integrins, the
inability of forced-expression of integrin-b3 in completely nullify-
ing the inhibitory action of let-7 precursor on blastocyst outgrowth
could be due to the involvement of other pathway(s) mediating the
action of of let-7 on embryo implantation. Each miRNA can
regulate the expression of a large number of genes. Other than
integrin-b3, let-7 is known to regulate RAS [66], HMGA2 [67]
and Dicer [68]. Among the potential pathways predicted from
miRNAs differentially expressed between dormant and activated
blastocysts, the Wnt pathway may be relevant to the observed
action of let-7. Two miRNAs target gene prediction softwares,
TargetScan and PicTar show that Kremen1 and Wnt1 are target
genes of let-7. Wnt1 is predominantly expressed in the inner cell
mass of mouse blastocyst [69], while Kremen1 is detected
primarily in the trophectoderm of dormant blastocysts and is
translocated into the nuclei of trophodermal cells in activated
blastocysts [47]. The contribution of the Wnt pathway to the
action of let-7 is being investigated.
Let-7 family members have also been implicated in the early
pregnancy. Several of the let-7 members are upregulated in the
delayed implantating mouse uterus after activation [70] and in the
implantation site relative to inter-implantation site [71]. Both the
luminal epithelium and the stroma of endometrium express let-7
members with unknown function [71,72]. Integrin-b3 is expressed
in the uterine luminal epithelium of mice [73] and rats [74].
Interestingly, the expression of integrin-b3 in the latter [74] but
not the former [73] is under steroid control. Whether let-7
Figure 4. The effects of let-7a on the embryo attachment, percentage outgrowth and outgrowth area in vitro. Eight-cell embryos were
electroporated with precursor of let-7a or control RNA, and cultured on fibronectin coated dishes. (a) Let-7a inhibited blastocyst attachment on
fibronectin after 36-hour of culture. (b) let-7a reduced the number of attached blastocysts showing trophoblast outgrowth rate after 48-hour of
culture. (c) let-7a decreased the trophoblast outgrowth area after 72-hour of culture. Each experiment consisted of 25–30 embryos and the
experiment was repeated at least 5 times (*P,0.05, One-way ANOVA).
doi:10.1371/journal.pone.0037039.g004
Figure 5. Let-7a interacts with the 39-untranslated region (UTR)
of integrin b3. (a) The potential let-7a binding site in mouse integrin-
b3 (Itgb3). (b) Luciferase activities of the wild type or mutated integrin-
b33 9UTR reporter constructs co-electroporated with the let-7a
precursor in HeLa cells. Dual luciferase assays were performed in cell
lysates at 48-hour post-electroporation. (c) Western blot analysis of
integrin-b3 protein from blastocysts electroporated with pre-let7a or
control RNA at the 8-cell embryo stage. Each lane contained extract
from 40 blastocysts. Semi-quantitative analysis of integrin-b3 expression
levels in the embryos. There was a significant decrease in integrin-b3
protein expression in embryos eclectroporated with pre-let-7a relative
to the control. The data represent the mean and standard errors (n=3).
*denotes P,0.05.
doi:10.1371/journal.pone.0037039.g005
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epithelium remains to be determined.
In conclusion, this study reported the differential expression of
miRNAs between dormant and activated blastocysts. The results
showed that let-7 is involved in the regulation of blastocyst
activation. The knowledge gained may be applied to humans as
a continuous down-regulation of let-7 is also observed in the
human preimplantation embryos. The present investigation
provides information on a novel mechanism in the initiation of
embryo implantation.
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